Search

M22™ - Think Outside the Eye

M22

Think Outside the Eye

 
Skin and eyelid inflammation affects millions of Americans every year. Over 85% of skin and eyelid inflammation patients also suffer from inflammatory ocular conditions, such as Meibomian Gland Dysfunction (MGD), blepharitis, eyelid inflammation and eyelid telangiectasia1.

Lumenis invites you to think outside the eye and offer your patients a solution to their skin inflammation and skin related problems with M22™. M22™ combines Intense Pulsed Light (IPL) with unique Optimal Pulse Technology (OPT™), and is FDA cleared for 20 different skin indications, including rosacea treatment and other skin inflammatory conditions2

 

 

get a DEMO

IPL: An Excellent Technology for Treating Skin and Eyelid Inflammation 

Inflammatory skin diseases are characterized by the formation of vascular abnormalities, which release inflammatory agents. When occurring in proximity to the eyes, these mediators propagate via the orbital vasculature to the eyelids, often resulting in inflammation of the eyelids and triggering ocular complications.

IPL is an excellent technology for treating vascular skin lesions. IPL is selectively absorbed in the hemoglobin of abnormal blood vessels, and destroys them by thrombosis. A major source of inflammation threatening the eyelids is then removed.

Learn More

 

M22 IPL WITH OPT CENTERS OF EXCELLENCE


OPT is the latest IPL (Intense Pulsed Light) technology in the market, unique to Lumenis M22.
OPT controls pulse shape by equalizing energy distribution over the entire pulse or sequential pulses – for safer, reproducible results.

Lumenis Ophthalmology – IPL Treatment

References:

¹ Viso E, Millán AC, and Rodríguez-Ares MT, Rosacea-associated meibomian gland dysfunction - an epidemiological perspective, Eur Ophthalmol Rev, 2014; 8(1):13-16.
² Weinkle AP, Doktor V, Emer J., Update on the Management of Rosacea, Clin Cosmet Investig Dermatol, 2015; 8:159-77.


 

Related Links

  SLT Therapy for Glaucoma


Caution: Federal (US) law restricts Lumenis devices to sale by or on the order of a licensed practitioner.

PB-2006798 Rev A